Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Ocala Oncology Center

     
Ocala , FL 34471
USA

 

Principal Investigator:
 Thomas Cartwright, MD
Contact:
 Patricia Marotta 352-732-4938 patricia.marotta@usoncology.com
Activation Status of this Site:
 Closed
Notes about this Site:
Ocala Oncology Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.